bingoparty| ST Red Sun (000525.SZ): Huazhou Pharmaceutical plans to invest and establish a joint venture company to carry out related businesses such as research and development and production of the biological enzyme industry

Gronghui May 10 丨ST Red Sun (000525bingoparty.SZ) announcedbingopartyBased on the company's actual operating and strategic development needs, the company's wholly-owned grandson company Nanjing Huazhou Pharmaceutical Co., Ltd.(referred to as "Huazhou Pharmaceutical"), Beijing China Science and Technology Expo Industry Information Technology Research Institute Co., Ltd.(referred to as "China Science and Technology Expo") and Mr. Zhang Lanping, plan to jointly fund the establishment of "Nanjing Red Sun Biological Enzyme Engineering Technology Co., Ltd.(referred to as the" Joint Venture Company ", ultimately subject to the name approved by industrial and commercial registration)" to carry out related businesses such as research and development and production of the biological enzyme industry. The registered capital of the joint venture company is proposed to be 10 million yuan, of which: Huazhou Pharmaceutical contributes 7 million yuan, holding 70% equity; Zhongke Bohou contributes 2 million yuan, holding 20% equity; and Mr. Zhang Lanping contributes 1 million yuan, holding 10% equity.